insider24.ch
Back to the feed

Shareholding disclosure

UBS AG

inVifor Pharma AG

Declared position

3%

Threshold

Fell below threshold

Timeline

Published

15.04.2014

Transaction

08.04.2014

Transfer date

08.04.2014

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAE4B00024

Beneficial owner

UBS AG

Declared address

UBS AG, 8098 Zürich

UBS Global Asset Management Holding (No. 2) Ltd, 21 Lombard Street, London EC3V 9AH, United Kingdom is holding indirectly through: UBS Global Asset Management Holding Ltd, 21 Lombard Street, London EC3V 9AH, United Kingdom is holding indirectly through: UBS Global Asset Management Life Ltd, 21 Lombard Street, London EC3V 9AH, United Kingdom. UBS Global Asset Management (Australia) Ltd, Level 16, Chifley Tower, 2 Chifley Square, Sydney, NSW 2000, Australia, UBS Global Asset Management (Singapore) Ltd, One Raffles Quay, #50-01 North Tower, Singapore, 048583, Singapore and UBS Global Asset Management Holding (No. 2) Ltd, Lombard Street, London EC3V 9AH, United Kingdom are directly held (100 %) by UBS AG, Bahnhofstrasse 45, 8098 Zürich

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open